LSL Pharma Group Inc. (TSXV:LSL)
Canada · Delayed Price · Currency is CAD 0.3150
-0.0050 (-1.56%)
Sep 18, 2026, 3:10 PM EST
LSL Pharma Group Market Cap
LSL Pharma Group has a market cap or net worth of CAD 39.92 million as of September 18, 2026. Its market cap has decreased by -13.34% in one year.
Market Cap
39.92M
Enterprise Value
89.55M
Revenue
41.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.32
ChartMarket Cap Chart
Since March 2, 2023, LSL Pharma Group's market cap has decreased from 61.67M to 39.92M, a decrease of -35.27%. That is a compound annual growth rate of -11.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 39.92M | -5.91% |
| Dec 31, 2025 | 42.43M | -10.43% |
| Dec 31, 2024 | 47.37M | 18.48% |
| Dec 29, 2023 | 39.98M | -35.17% |
| Mar 2, 2023 | 61.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Planet 13 Holdings | 65.39M |
| ZYUS Life Sciences | 60.39M |
| BioNxt Solutions | 53.08M |
| Optimi Health | 39.51M |
| Voyageur Pharmaceuticals | 38.48M |
| 1CM Inc. | 35.32M |
| iAnthus Capital Holdings | 34.87M |
| MediPharm Labs | 32.04M |